The company published trial design and preliminary data from the adaptive DBS algorithm for personalised therapy in Parkinson’s disease (ADAPT-PD) trial.

JPM24: FDA approves Medtronic’s rechargeable deep brain stimulator for Parkinson’s ... green lights near the top of this year ...

Medtronic (NYSE: MDT) today announced the publication of its novel approach to studying adaptive deep brain stimulation (aDBS ...

Abbott Laboratories will begin clinical trials for its deep-brain stimulation system for treatment-resistant depression after receiving Breakthrough Device designation from the U.S. Food and Drug ...

[35] Involvement of pain matrix brain areas is also suggested by the ... one patient died for reasons other than the neurostimulator and in another patient the electrode was removed owing to ...

A team at ETH Zurich is pushing the boundaries of what can be achieved with neurostimulation and neuronal recording ...

The neurostimulator, which sends electrical signals deep into his brain, has reduced Oran Knowlson’s daytime seizures by 80%. His mother, Justine, told the BBC he was happier and had a “much ...

Deep brain stimulation (DBS), which involves implanting ... connected via wires that run down through the neck to a neurostimulator that is inserted just under the skin, usually near the collarbone.

The specific type of operation that Rust had is called a deep brain stimulation ... the electric current from the neurostimulator passes through the wires and into the brain.

What if we could resist compulsions? These irrational behaviors, particularly common in obsessive-compulsive disorder (OCD), ...

Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical ...